ReVenG: A phase 2 study of venetoclax plus obinutuzumab retreatment in relapsed chronic lymphocytic leukaemiaMatthew Davids,Kirsten Fischer,Sandra Robrecht,Can Zhang,Inhye Ahn,Michele Porro Lura,Wendy Sinai,Brenda Chyla,Kavita Sail,John Pesko,Madhavi Pai,Viktor Komlosi,Michael Hallek,Jennifer Brown,Othman Al-SawafBRITISH JOURNAL OF HAEMATOLOGY(2023)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要